Ambreen Azhar, United States
Molecular and Histological Insights into BK Virus-Associated Nephropathy in Kidney Transplant Recipients

Ambreen Azhar, United States
"Immune Predictors of BK Viremia Clearance: Role of BK Virus-Specific T-Cell Immunity in Kidney Transplant Recipients"

Elizabeth Hendren, Canada
Changes in the Duration and Severity of BK Viral Load May as a Surrogate Outcome in Trials to Advance New Therapeutics for BK Virus

Matthew D'Costa, Singapore
Intravenous Immunoglobulin as Adjunctive Treatment for BK DNAemia

Hye Eun Kwon, Korea
Comparative Analysis of Immunosuppressant Adjustments in BK Viremia Management: Sirolimus, Leflunomide, and MMF Tapering

Alexis Piedrafita, France
RNASeq Changes Associated with Polyomavirus-Associated Nephropathy: From Pathophysiology to Drug Repurposing

Hsu-Han Wang, Taiwan
Adding on mTOR Inhibitors May Help Reducing Viral Load in BK Polyomavirus Infection After Kidney Transplantation

Nicole Clarke, United States
The Risk Factors Developing BK Viraemia and Its Viral Kinetics in Kidney Transplant Recipients